335 research outputs found

    Demonstration of the multimaterial coating concept to reduce thermal noise in gravitational-wave detectors

    Get PDF
    Thermal noise associated with the mechanical loss of current highly reflective mirror coatings is a critical limit to the sensitivity of gravitational-wave detectors. Several alternative coating materials show potential for reducing thermal noise, but cannot be used due to their high optical absorption. Multimaterial coatings have been proposed to enable the use of such materials to reduce thermal noise while minimizing their impact on the total absorption of the mirror coating. Here we present experimental verification of the multimaterial concept, by integrating aSi into a highly reflective SiO2 and Ta2O5 multilayer coating. We show a significant thermal noise improvement and demonstrate consistent optical and mechanical performance. The multimaterial coating survives the heat treatment required to minimize the absorption of the aSi layers, with no adverse effects from the different thermomechanical properties of the three materials

    Erasure detection of a dual-rail qubit encoded in a double-post superconducting cavity

    Full text link
    Qubits with predominantly erasure errors present distinctive advantages for quantum error correction(QEC) and fault tolerant quantum computing. Logical qubits based on dual-rail encoding that exploit erasure detection have been recently proposed in superconducting circuit architectures, either with coupled transmons or cavities. Here, we implement a dual-rail qubit encoded in a compact, double-post superconducting cavity. Using an auxiliary transmon, we perform erasure detection on the dual-rail subspace. We characterize the behaviour of the codespace by a novel method to perform joint-Wigner tomography. This is based on modifying the cross-Kerr interaction between the cavity modes and the transmon. We measure an erasure rate of 3.981 +/- 0.003 (ms)-1 and a residual dephasing error rate up to 0.17 (ms)-1 within the codespace. This strong hierarchy of error rates, together with the compact and hardware-efficient nature of this novel architecture, hold promise in realising QEC schemes with enhanced thresholds and improved scaling

    Superoxide dismutase SodB is a protective antigen against Campylobacter jejuni colonisation in chickens

    Get PDF
    Campylobacter is the leading cause of foodborne diarrhoeal illness in the developed world and consumption or handling of contaminated poultry meat is the principal source of infection. Strategies to control Campylobacter in broilers prior to slaughter are urgently required and are predicted to limit the incidence of human campylobacteriosis. Towards this aim, a purified recombinant subunit vaccine based on the superoxide dismutase (SodB) protein of C. jejuni M1 was developed and tested in White Leghorn birds. Birds were vaccinated on the day of hatch and 14 days later with SodB fused to glutathione S-transferase (GST) or purified GST alone. Birds were challenged with C. jejuni M1 at 28 days of age and caecal Campylobacter counts determined at weekly intervals. Across three independent trials, the vaccine induced a statistically significant 1 log10 reduction in caecal Campylobacter numbers in vaccinated birds compared to age-matched GST-vaccinated controls. Significant induction of antigen-specific serum IgY was detected in all vaccinated birds, however the magnitude and timing of SodB-specific IgY did not correlate with lower numbers of C. jejuni. Antibodies from SodB-vaccinated chickens detected the protein in the periplasm and not membrane fractions or on the bacterial surface, suggesting that the protection observed may not be strictly antibody-mediated. SodB may be useful as a constituent of vaccines for control of C. jejuni infection in broiler birds, however modest protection was observed late relative to the life of broiler birds and further studies are required to potentiate the magnitude and timing of protection

    Human Cytomegalovirus Induces TGF-β1 Activation in Renal Tubular Epithelial Cells after Epithelial-to-Mesenchymal Transition

    Get PDF
    Human cytomegalovirus (HCMV) infection is associated epidemiologically with poor outcome of renal allografts due to mechanisms which remain largely undefined. Transforming growth factor-β1 (TGF-β1), a potent fibrogenic cytokine, is more abundant in rejecting renal allografts that are infected with either HCMV or rat CMV as compared to uninfected, rejecting grafts. TGF-β1 induces renal fibrosis via epithelial-to-mesenchymal transition (EMT) of renal epithelial cells, a process by which epithelial cells acquire mesenchymal characteristics and a migratory phenotype, and secrete molecules associated with extracellular matrix deposition and remodeling. We report that human renal tubular epithelial cells infected in vitro with HCMV and exposed to TGF-β1 underwent morphologic and transcriptional changes of EMT, similar to uninfected cells. HCMV infected cells after EMT also activated extracellular latent TGF-β1 via induction of MMP-2. Renal epithelial cells transiently transfected with only the HCMV IE1 or IE2 open reading frames and stimulated to undergo EMT also induced TGF-β1 activation associated with MMP-2 production, suggesting a role for these viral gene products in MMP-2 production. Consistent with the function of these immediate early gene products, the antiviral agents ganciclovir and foscarnet did not inhibit TGF-β1 production after EMT by HCMV infected cells. These results indicate that HCMV infected renal tubular epithelial cells can undergo EMT after exposure to TGF-β1, similar to uninfected renal epithelial cells, but that HCMV infection by inducing active TGF-β1 may potentiate renal fibrosis. Our findings provide in vitro evidence for a pathogenic mechanism that could explain the clinical association between HCMV infection, TGF-β1, and adverse renal allograft outcome

    Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components

    Get PDF
    Immunotoxins and antibody-drug conjugates are protein-based drugs combining a target-specific binding domain with a cytotoxic domain. Such compounds are potentially therapeutic against diseases including cancer, and several clinical trials have shown encouraging results. Although the targeted elimination of malignant cells is an elegant concept, there are numerous practical challenges that limit conjugates’ therapeutic use, including inefficient cellular uptake, low cytotoxicity, and off-target effects. During the preparation of immunoconjugates by chemical synthesis, the choice of the hinge component joining the two building blocks is of paramount importance: the conjugate must remain stable in vivo but must afford efficient release of the toxic moiety when the target is reached. Vast efforts have been made, and the present article reviews strategies employed in developing immunoconjugates, focusing on the evolution of chemical linkers

    North American blastomycosis

    Full text link
    North American blastomycosis (Gilchrist's disease) in a granulomatous, infectious disease caused by the fungus, Blastomyces dermatitidis (Gilchrist and Stokes, 1898). The malady, in its cutaneous form, was first described by Gilchrist1 in 1894. A few years later, together with Stokes, he was able to isolate and culture that causative organisms which he designated as B. dermatitibis.23 The first description of the disease in its systemic form was made by Walker and Montgomery4 in 1902.The first reports by Gilchrist were followed by an era of confusion during which the disease was confounded with other entities, particularly cryptococcosis and candidiasis, all caused by morphologically similar budding organisms. Nineteen new names were suggested for the causative fungus. During the last two decades, however, a clearer picture of the disease process has emerged, particularly as a result of studies by the Duke Medical School group, headed by Smith, Martin, and Conant. Numerous clinical and laboratory reports have contributed significantly to a fuller understanding of the disease, but there are still some fundamental question to be answered. Excellent review articles on North American blastomycosis are available.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/32504/1/0000592.pd
    • …
    corecore